Research Article

Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias

Table 1

Characteristics of healthy volunteers and patients with IIPs.

Healthy controlUIPNSIPCOP
1223177 value

Age64.3 ± 3.165.3 ± 1.654.3 ± 2.764.0 ± 3.90.015
Female (%)6 (50.0)10 (43.5)8 (46.6)2 (28.6)n.s
Smoke (%)6 (50.0)12 (52.2)5 (29.4)4 (57.2)n.s
Pulmonary function tests
 FVC (L)3.03 ± 0.242.48 ± 0.192.55 ± 0.302.19 ± 0.23n.s
 FVC (%)112.7 ± 3.083.3 ± 4.278.4 ± 7.268.3 ± 5.9n.s
 FEV/FVC (%)77.8 ± 2.187.6 ± 2.085.0 ± 1.4181.4 ± 1.9n.s
 DLco (%)114.2 ± 7.673.7 ± 5.167.8 ± 6.963.4 ± 4.8n.s
Lung specimens obtained
 Upper lobe (%)6 (50.0)5 (21.7)1 (5.8)1 (14.3)n.s
 Lower lobe (%)6 (50.0)7 (30.4)3 (17.6)3 (42.9)n.s
 Both lobes (%)0 (0)11 (47.8)13 (76.5)3 (42.9)<0.001
Treatments
 Corticosteroid (%)0 (0)4 (17.4)13 (74.5)5 (71.4)<0.001
 Immunosuppresants (%)0 (0)2 (8.7)5 (29.4)0 (0)n.s
 Pirfenidone (%)0 (0)2 (8.7)1 (5.9)0 (0)n.s
 None (%)12 (100.0)16 (69.6)3 (17.6)2 (28.6)<0.001

Data are shown as mean ± SD. Brackets represent percentage. IPF/UIP: idiopathic pulmonary fibrosis/usual interstitial pneumonia; NSIP: nonspecific interstitial pneumonia; COP: cryptogenic organizing pneumonia; FVC: forced vital capacity; FEV1.0: forced expiratory volume in 1 second; DLco: diffusing capacity of the lungs for carbon monoxide; n.s: no statistical significance.